SCYX –just sold their golden egg?
by healeydriver | July 15, 2016 12:35 pm
Dr KSS wrote about SCYX last month. He explained how they have an anti-fungal drug underway that would be very helpful as an adjunct to the many anti-bacterial drugs already on the market. An anti-fungal would be a bit unique and therefore valuable, he explained. However, I just read that SCYX sold their product (all their cyclophilin inhibitor assets). Does this mean they just sold out of their rights to the anti-fungal material Dr. KSS[1] was discussing?
Endnotes:
- Dr. KSS: https://www.stockgumshoe.com/tag/dr-kss/
Source URL: https://www.stockgumshoe.com/2016/07/microblog-scyx-just-sold-their-golden-egg/
I’m no medical expert but it seems that SCYX only sold non-core assets, not the ones that Dr KSS wrote about.
See: https://globenewswire.com/news-release/2016/07/13/855696/0/en/SCYNEXIS-Inc-Announces-Sale-of-Cyclophilin-Inhibitor-Assets-to-Cypralis-Limited.html
All the best MK
I would really LOVE an update on what has been/is going on with SCYX.
I see that it is up 28% today — and I could exit with a nice profit.
However, if Dr. KSS thinks it’s still the potentially potent long term play he originally did, I’m more than willing to be patient.
I may just not be searching efficiently, but I can’t seem to find ANY recent substantive posts about this stock– have I quite literally “lost the thread”?
SCYX long – Tony, articles by author KSS most recent alway on top. 🙂 http://www.stockgumshoe.com/author/dr-kss-md-phd/ Best2You-Ben